The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10X GENOMICS INC | CL A COM | 88025U109 | 1,125,900 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
ABCELLERA BIOLOGICS INC | COM | 00288U106 | 8,108,700 | 1,790,000 | SH | SOLE | 1,790,000 | 0 | 0 | ||
ABSCI CORPORATION | COM | 00091E109 | 142,000 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
ADC THERAPEUTICS SA | SHS | H0036K147 | 31,655,847 | 7,050,300 | SH | SOLE | 7,050,300 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 731,000 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 5,820,050 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
AVROBIO INC | COM | 05455M100 | 725,144 | 566,519 | SH | SOLE | 566,519 | 0 | 0 | ||
BARRETT BUSINESS SVCS INC | COM | 068463108 | 3,041,280 | 24,000 | SH | SOLE | 24,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 7,112,000 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 1,121,250 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 18,228,268 | 589,530 | SH | SOLE | 589,530 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 3,732,960 | 555,500 | SH | SOLE | 555,500 | 0 | 0 | ||
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 3,948,211 | 100,617 | SH | SOLE | 100,617 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 17,176,950 | 245,000 | SH | SOLE | 245,000 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 3,190,100 | 23,000 | SH | SOLE | 23,000 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 7,539,095 | 3,659,755 | SH | SOLE | 3,659,755 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 29,994,686 | 931,512 | SH | SOLE | 931,512 | 0 | 0 | ||
GUARDANT HEALTH INC | COM | 40131M109 | 9,696,100 | 470,000 | SH | SOLE | 470,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 6,300,450 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
KELLY SVCS INC | CL A | 488152208 | 8,731,097 | 348,686 | SH | SOLE | 348,686 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 868,780 | 963,598 | SH | SOLE | 963,598 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 20,476,800 | 960,000 | SH | SOLE | 960,000 | 0 | 0 | ||
LENZ THERAPEUTICS INC | COM | 52635N103 | 1,451,450 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
MARAVAI LIFESCIENCES HLDGS I | COM CL A | 56600D107 | 5,197,318 | 599,460 | SH | SOLE | 599,460 | 0 | 0 | ||
MEDTRONIC PLC | SHS | G5960L103 | 15,687,000 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
MEIRAGTX HLDGS PLC | COM | G59665102 | 24,385,017 | 4,017,301 | SH | SOLE | 4,017,301 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 11,680,800 | 465,000 | SH | SOLE | 465,000 | 0 | 0 | ||
MURAL ONCOLOGY PUB LTD CO | ORD SHS | G63365103 | 1,956,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 4,206,560 | 30,500 | SH | SOLE | 30,500 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 910,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
OPTION CARE HEALTH INC | COM NEW | 68404L201 | 3,354,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ORTHOPEDIATRICS CORP | COM | 68752L100 | 12,196,491 | 418,261 | SH | SOLE | 418,261 | 0 | 0 | ||
OVID THERAPEUTICS INC | COM | 690469101 | 2,998,760 | 983,200 | SH | SOLE | 983,200 | 0 | 0 | ||
PACIRA BIOSCIENCES INC | COM | 695127100 | 2,757,258 | 94,362 | SH | SOLE | 94,362 | 0 | 0 | ||
PFIZER INC | COM | 717081103 | 5,966,250 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
PRIVIA HEALTH GROUP INC | COM | 74276R102 | 881,550 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 4,222,517 | 170,469 | SH | SOLE | 170,469 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 3,735,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | 19,604,400 | 1,860,000 | SH | SOLE | 1,860,000 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 33,301,500 | 3,725,000 | SH | SOLE | 3,725,000 | 0 | 0 | ||
UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 5,473,800 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 3,201,772 | 39,046 | SH | SOLE | 39,046 | 0 | 0 | ||
ZIMMER BIOMET HOLDINGS INC | COM | 98956P102 | 2,495,478 | 18,908 | SH | SOLE | 18,908 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985Y108 | 4,323,173 | 410,948 | SH | SOLE | 410,948 | 0 | 0 |